MARKET

ATHE

ATHE

Alterity Therapeutics Ltd
NASDAQ
2.130
+0.090
+4.41%
Pre Market: 2.130 0 0.00% 08:52 04/24 EDT
OPEN
2.100
PREV CLOSE
2.130
HIGH
2.200
LOW
2.035
VOLUME
129
TURNOVER
0
52 WEEK HIGH
5.41
52 WEEK LOW
1.550
MARKET CAP
18.59M
P/E (TTM)
-1.0504
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 27.8% to $0.58 during Wednesday's regular session. The company's market cap stands at $4.4 million. Prenetics Global and Alterity Therapeutics also moved upwards.
Benzinga · 54m ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. ABVC BioPharma and Medpace Hldgs stock increased by 5.15%. Fresh2 Group shares fell 12.9% during the session.
Benzinga · 20h ago
Weekly Report: what happened at ATHE last week (0415-0419)?
Weekly Report · 2d ago
Alterity Therapeutics Parkinson's Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Three posters were presented at the American Academy of Neurology 2024 Annual Meeting in Denver, Colorado. The Company's work in Parkinson's disease and Multiple System Atrophy is described. Alterity Therapeutics is a biotechnology company dedicated to developing treatments for neurodegenerative diseases.
Benzinga · 04/17 11:26
Alterity Therapeutics Showcases Promising Neurodegenerative Drug Data
TipRanks · 04/17 10:57
Alterity Therapeutics Expands Securities Quotation
Alterity Therapeutics Limited announced the application for the quotation of additional securities. The company has issued options expiring on August 31, 2026. The move could potentially impact the company’s stock performance and investor interest. ATHE stock is down 2% in the last week.
TipRanks · 04/16 00:57
12 Health Care Stocks Moving In Monday's After-Market Session
Dynatronics (NASDAQ:DYNT) stock increased by 70.1% to $0.63 during Monday's after-market session. Cardio Diagnostics Hldgs stock rose 14.28% and Aptorum Gr shares rose 12.61%. Poseida Therapeutics ( NASDAQ:PSTX) shares declined by 15.2% during the session.
Benzinga · 04/15 20:31
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. The company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome. Soligenix, Inc. Shares surged 71.5% after the company was granted orphan drug designation for MarVax.
Benzinga · 04/15 18:11
More
About ATHE
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.

Webull offers Alterity Therapeutics Ltd (ADR) stock information, including NASDAQ: ATHE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATHE stock methods without spending real money on the virtual paper trading platform.